Últimos Artículos de Lancet Diabetes & Endocrinology
- [In Focus] Integrating mental health and non-communicable disease care: from declarations to practice
- [Correspondence] GLP-1 receptor agonists for obesity: eligibility across 99 countries
- [Comment] Circadian and sleep medicine: challenges and future directions for metabolic and endocrine research
- [Editorial] Aligning diabetes surveillance with clinical reality
- [Articles] Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
- [Comment] Does siRNA therapy against ANGPTL3 bring new hope in homozygous familial hypercholesterolaemia?
- [Review] Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement
- [Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 162–73
- [Articles] 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050
- [Comment] Embracing multiplicity in global diabetes estimation methods
- [Comment] Defining prediabetes remission as a distinct prevention endpoint
- [Comment] Preventing cardiovascular risk in people with prediabetes
- [Articles] Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study
- [Correspondence] Genetic risk-targeted islet autoantibody screening for presymptomatic type 1 diabetes in adults
- [Comment] Staging prediabetes and type 2 diabetes: the time to start is now
- [Correspondence] Task shifting and task sharing in paediatric type 1 diabetes care: a global survey
- [Personal View] Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology
- [Personal View] Obesity in China: current progress and future prospects
- [Correspondence] Social learning theories and metabolic health: the centenary of Bandura's birth
- [Editorial] Diabetes and cancer in the age of multimorbidity